LABU vs. FLYU
LABU (Direxion Daily S&P Biotech Bull 3x Shares) and FLYU (MicroSectors Travel 3X Leveraged ETNs) are both Leveraged Equities funds - LABU tracks the S&P Biotechnology Select Industry Index (300%) while FLYU tracks the MerQube MicroSectors U.S. Travel Index. Both are passively managed. Over the past 3 years, LABU returned 7.22%/yr vs 7.70%/yr for FLYU. A 0.51 correlation means they provide meaningful diversification when combined. LABU charges 1.12%/yr vs 0.95%/yr for FLYU.
Performance
LABU vs. FLYU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABU achieves a 6.64% return, which is significantly higher than FLYU's -21.17% return.
LABU
- 1D
- 6.80%
- 1M
- -10.49%
- YTD
- 6.64%
- 6M
- 8.23%
- 1Y
- 184.28%
- 3Y*
- 7.22%
- 5Y*
- -35.06%
- 10Y*
- -12.12%
FLYU
- 1D
- 4.36%
- 1M
- 2.66%
- YTD
- -21.17%
- 6M
- -14.34%
- 1Y
- -7.94%
- 3Y*
- 7.70%
- 5Y*
- —
- 10Y*
- —
LABU vs. FLYU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
LABU Direxion Daily S&P Biotech Bull 3x Shares | 6.64% | 79.17% | -26.02% | -13.41% | 22.96% |
FLYU MicroSectors Travel 3X Leveraged ETNs | -21.17% | -2.29% | 33.00% | 111.16% | -19.09% |
Correlation
The correlation between LABU and FLYU is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.48 |
Correlation (All Time) Calculated using the full available price history since Jun 22, 2022 | 0.51 |
The correlation between LABU and FLYU has been stable across timeframes, ranging from 0.43 to 0.51 - a consistent structural relationship.
LABU vs. FLYU - Sectors Allocation Comparison
Sectors
LABU
FLYU
Healthcare
-
Financial Services
-
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
-
Healthcare
LABU
FLYU
-
Financial Services
LABU
FLYU
-
Basic Materials
LABU
FLYU
-
Communication Services
LABU
-
FLYU
Consumer Cyclical
LABU
-
FLYU
Consumer Defensive
LABU
-
FLYU
-
Energy
LABU
-
FLYU
-
Industrials
LABU
-
FLYU
Real Estate
LABU
-
FLYU
Technology
LABU
-
FLYU
Utilities
LABU
-
FLYU
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABU vs. FLYU — Risk / Return Rank
LABU
FLYU
LABU vs. FLYU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and MicroSectors Travel 3X Leveraged ETNs (FLYU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABU | FLYU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.51 | ||
| Sortino ratioReturn per unit of downside risk | +2.42 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.04 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 6.04 | -0.15 | +6.19 |
| Martin ratioReturn relative to average drawdown | 17.12 | -0.32 | +17.44 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LABU | FLYU | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.41 | -0.11 | +2.51 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.37 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.13 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.23 | 0.18 | -0.42 |
Drawdowns
LABU vs. FLYU - Drawdown Comparison
The maximum LABU drawdown since its inception was -99.18%, which is greater than FLYU's maximum drawdown of -69.00%. Use the drawdown chart below to compare losses from any high point for LABU and FLYU.
Loading charts...
Drawdown Indicators
| LABU | FLYU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.18% | -69.00% | -30.18% |
Max Drawdown (1Y)Largest decline over 1 year | -30.70% | -52.33% | +21.63% |
Max Drawdown (3Y)Largest decline over 3 years | -78.30% | -69.00% | -9.30% |
Max Drawdown (5Y)Largest decline over 5 years | -97.59% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -98.96% | — | — |
Current DrawdownCurrent decline from peak | -96.24% | -37.47% | -58.77% |
Average DrawdownAverage peak-to-trough decline | -81.67% | -26.49% | -55.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.81% | 24.86% | -14.05% |
Volatility
LABU vs. FLYU - Volatility Comparison
Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a higher volatility of 29.37% compared to MicroSectors Travel 3X Leveraged ETNs (FLYU) at 20.50%. This indicates that LABU's price experiences larger fluctuations and is considered to be riskier than FLYU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABU | FLYU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.37% | 20.50% | +8.87% |
Volatility (6M)Calculated over the trailing 6-month period | 60.90% | 57.30% | +3.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.11% | 73.75% | +3.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 95.62% | 83.01% | +12.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.44% | 83.01% | +12.43% |
LABU vs. FLYU - Expense Ratio Comparison
LABU has a 1.12% expense ratio, which is higher than FLYU's 0.95% expense ratio.
Dividends
LABU vs. FLYU - Dividend Comparison
LABU's dividend yield for the trailing twelve months is around 0.72%, while FLYU has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
FLYU MicroSectors Travel 3X Leveraged ETNs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.72% | 0.84% | 0.35% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
Frequently Asked Questions
LABU and FLYU have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABU has higher volatility (29.37%) compared to FLYU (20.50%). In terms of maximum drawdown, LABU dropped -99.18% vs FLYU's -69.00%.
On 3-year performance, FLYU leads with 7.70% vs 7.22% for LABU. On fees, FLYU is cheaper at 0.95% per year. On volatility, FLYU has been the lower-risk option at 20.50%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, FLYU has performed better with a 7.70% return vs 7.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FLYU is cheaper with a 0.95% expense ratio, compared with 1.12% for LABU.
LABU has the higher dividend yield at 0.72%, compared with 0.00% for FLYU.
LABU tracks S&P Biotechnology Select Industry Index (300%), while FLYU tracks MerQube MicroSectors U.S. Travel Index. They also come from different issuers: Direxion and REX. Their fees differ too: 1.12% for LABU and 0.95% for FLYU.
LABU currently has the higher Sharpe Ratio (2.41 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABU and FLYU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer